Details
Stereochemistry | ACHIRAL |
Molecular Formula | C43H49N7O9S |
Molecular Weight | 839.956 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COCCOCCOCCNC(=O)C1=CC(=CC(NC2=NC=CC(OC3=C4C=CC=CC4=C(NC(=O)NC5=CC(=CC(NS(C)(=O)=O)=C5OC)C(C)(C)C)C=C3)=N2)=C1)C#C
InChI
InChIKey=FWXVGKSWZJEPQI-UHFFFAOYSA-N
InChI=1S/C43H49N7O9S/c1-8-28-23-29(40(51)44-17-18-57-21-22-58-20-19-55-5)25-31(24-28)46-41-45-16-15-38(49-41)59-37-14-13-34(32-11-9-10-12-33(32)37)47-42(52)48-35-26-30(43(2,3)4)27-36(39(35)56-6)50-60(7,53)54/h1,9-16,23-27,50H,17-22H2,2-7H3,(H,44,51)(H,45,46,49)(H2,47,48,52)
Molecular Formula | C43H49N7O9S |
Molecular Weight | 839.956 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 14:08:35 GMT 2023
by
admin
on
Sat Dec 16 14:08:35 GMT 2023
|
Record UNII |
19ZTZ9YC4O
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1630202-02-6
Created by
admin on Sat Dec 16 14:08:35 GMT 2023 , Edited by admin on Sat Dec 16 14:08:35 GMT 2023
|
PRIMARY | |||
|
19ZTZ9YC4O
Created by
admin on Sat Dec 16 14:08:35 GMT 2023 , Edited by admin on Sat Dec 16 14:08:35 GMT 2023
|
PRIMARY | |||
|
81689783
Created by
admin on Sat Dec 16 14:08:35 GMT 2023 , Edited by admin on Sat Dec 16 14:08:35 GMT 2023
|
PRIMARY | |||
|
300000041472
Created by
admin on Sat Dec 16 14:08:35 GMT 2023 , Edited by admin on Sat Dec 16 14:08:35 GMT 2023
|
PRIMARY | |||
|
DB14839
Created by
admin on Sat Dec 16 14:08:35 GMT 2023 , Edited by admin on Sat Dec 16 14:08:35 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
TOP1288 demonstrated efficacious and potent inhibition (IC50 values from 0.6 - 77nM) against pro-inflammatory cytokine release from peripheral blood mononuclear cells from healthy donors, primary macrophages and HT29 epithelial cells.
IC50
|
||
|
TARGET -> INHIBITOR |
NARROW SPECTRUM KINASE INHIBITOR (NSKI) IN CLINICAL DEVELOPMENT AS AN ANTIINFLAMMATORY TREATMENT FOR ULCERATIVE COLITIS
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |